Zobrazeno 1 - 10 of 45 pro vyhledávání: '"Andras A. Heczey"'
2
Incidence and 5‐year survival of children and adolescents with hepatoblastoma in the United States
Autor: Justin A. Kahla, David A. Siegel, Shifan Dai, Philip J. Lupo, Jennifer H. Foster, Michael E. Scheurer, Andras A. Heczey
Publikováno v: Pediatric Blood & Cancer. 69
Hepatoblastoma (HB) is the most common pediatric primary malignant liver tumor, its incidence has been increasing worldwide, but recent changes in incidence and outcomes with high population coverage are not well characterized.We defined the incidenc
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b9a552b1f599bcb1d2a450fd5ca45d2a
https://doi.org/10.1002/pbc.29763
Zobrazit plný text záznamu
5
Akademický článek
The impact of congenital heart disease on treatment and survival of patients with hepatoblastoma: A single-center experience.
Autor: Espinoza AF; Division of Pediatric Surgery, Michael E. DeBakey Department of Surgery, Texas Children's Surgical Oncology Program and Liver Tumor Program, Dan L. Duncan Cancer Center, Baylor College of Medicine, Houston, Texas, USA., Montgomery AE; Division of Pediatric Surgery, Michael E. DeBakey Department of Surgery, Texas Children's Surgical Oncology Program and Liver Tumor Program, Dan L. Duncan Cancer Center, Baylor College of Medicine, Houston, Texas, USA., Maamari NC; Division of Pediatric Surgery, Michael E. DeBakey Department of Surgery, Texas Children's Surgical Oncology Program and Liver Tumor Program, Dan L. Duncan Cancer Center, Baylor College of Medicine, Houston, Texas, USA., Dickerson HA; Department of Pediatrics, Section of Pediatric and Adult Congenital Cardiology, Texas Children's Hospital, Baylor College of Medicine, Houston, Texas, USA., Heczey A; Department of Pediatric Hematology and Oncology, Texas Children's Hospital, Baylor College of Medicine, Houston, Texas, USA., Vasudevan SA; Division of Pediatric Surgery, Michael E. DeBakey Department of Surgery, Texas Children's Surgical Oncology Program and Liver Tumor Program, Dan L. Duncan Cancer Center, Baylor College of Medicine, Houston, Texas, USA., Foster JH; Department of Pediatric Hematology and Oncology, Texas Children's Hospital, Baylor College of Medicine, Houston, Texas, USA.
Publikováno v: Pediatric blood & cancer [Pediatr Blood Cancer] 2024 Nov; Vol. 71 (11), pp. e31214. Date of Electronic Publication: 2024 Aug 08.
Zobrazit plný text záznamu
6
Akademický článek
Incidence and survival of pediatric and adult hepatocellular carcinoma, United States, 2001-2020.
Autor: Arnett A; Cancer and Hematology Centers, Texas Children's Hospital, Houston, TX, United States; Division of Hematology-Oncology, Department of Pediatrics, Baylor College of Medicine, Houston, TX, United States., Siegel DA; Division of Cancer Prevention and Control, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, GA, United States., Dai S; Cyberdata Technologies, Inc., Herndon, VA, United States., Thompson TD; Division of Cancer Prevention and Control, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, GA, United States., Foster J; Cancer and Hematology Centers, Texas Children's Hospital, Houston, TX, United States; Division of Hematology-Oncology, Department of Pediatrics, Baylor College of Medicine, Houston, TX, United States., di Pierro EJ; Cancer and Hematology Centers, Texas Children's Hospital, Houston, TX, United States; Division of Hematology-Oncology, Department of Pediatrics, Baylor College of Medicine, Houston, TX, United States., Momin B; Division of Cancer Prevention and Control, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, GA, United States., Lupo PJ; Cancer and Hematology Centers, Texas Children's Hospital, Houston, TX, United States; Center for Epidemiology and Population Health, Department of Pediatrics, Baylor College of Medicine, Houston, TX, United States; Division of Hematology-Oncology, Department of Pediatrics, Baylor College of Medicine, Houston, TX, United States., Heczey A; Cancer and Hematology Centers, Texas Children's Hospital, Houston, TX, United States; Division of Hematology-Oncology, Department of Pediatrics, Baylor College of Medicine, Houston, TX, United States. Electronic address: heczey@bcm.edu.
Publikováno v: Cancer epidemiology [Cancer Epidemiol] 2024 Oct; Vol. 92, pp. 102610. Date of Electronic Publication: 2024 Jul 09.
Zobrazit plný text záznamu
7
Akademický článek
Prolonged cytopenias after immune effector cell therapy and lymphodepletion in patients with leukemia, lymphoma and solid tumors.
Autor: Miller A; Center for Cell and Gene Therapy, Baylor College of Medicine, Texas Children's Hospital and Houston Methodist Hospital, Houston, TX, USA., Daum R; Center for Cell and Gene Therapy, Baylor College of Medicine, Texas Children's Hospital and Houston Methodist Hospital, Houston, TX, USA; Dell Medical School, University of Texas at Austin, Austin, TX, USA., Wang T; Center for Cell and Gene Therapy, Baylor College of Medicine, Texas Children's Hospital and Houston Methodist Hospital, Houston, TX, USA; Dan L Duncan Comprehensive Cancer Center, Houston, TX, USA., Wu M; Center for Cell and Gene Therapy, Baylor College of Medicine, Texas Children's Hospital and Houston Methodist Hospital, Houston, TX, USA; Dan L Duncan Comprehensive Cancer Center, Houston, TX, USA., Tat C; Center for Cell and Gene Therapy, Baylor College of Medicine, Texas Children's Hospital and Houston Methodist Hospital, Houston, TX, USA; Department of Pediatrics, Texas Children's Hospital, Houston, TX, USA., Pfeiffer T; Center for Cell and Gene Therapy, Baylor College of Medicine, Texas Children's Hospital and Houston Methodist Hospital, Houston, TX, USA; Department of Pediatrics, Texas Children's Hospital, Houston, TX, USA; Department of Pediatrics, Division of Hematology/Oncology, Washington University School of Medicine, St. Louis, MO, USA., Navai S; Center for Cell and Gene Therapy, Baylor College of Medicine, Texas Children's Hospital and Houston Methodist Hospital, Houston, TX, USA; Department of Pediatrics, Texas Children's Hospital, Houston, TX, USA., Heczey A; Center for Cell and Gene Therapy, Baylor College of Medicine, Texas Children's Hospital and Houston Methodist Hospital, Houston, TX, USA; Dan L Duncan Comprehensive Cancer Center, Houston, TX, USA; Department of Pediatrics, Texas Children's Hospital, Houston, TX, USA., Hegde M; Center for Cell and Gene Therapy, Baylor College of Medicine, Texas Children's Hospital and Houston Methodist Hospital, Houston, TX, USA; Dan L Duncan Comprehensive Cancer Center, Houston, TX, USA; Department of Pediatrics, Texas Children's Hospital, Houston, TX, USA., Ahmed N; Center for Cell and Gene Therapy, Baylor College of Medicine, Texas Children's Hospital and Houston Methodist Hospital, Houston, TX, USA; Dan L Duncan Comprehensive Cancer Center, Houston, TX, USA; Department of Pediatrics, Texas Children's Hospital, Houston, TX, USA; Department of Pathology and Immunology, Baylor College of Medicine, Houston, TX, USA., Whittle SB; Dan L Duncan Comprehensive Cancer Center, Houston, TX, USA; Department of Pediatrics, Texas Children's Hospital, Houston, TX, USA., Hill L; Center for Cell and Gene Therapy, Baylor College of Medicine, Texas Children's Hospital and Houston Methodist Hospital, Houston, TX, USA; Dan L Duncan Comprehensive Cancer Center, Houston, TX, USA., Martinez C; Center for Cell and Gene Therapy, Baylor College of Medicine, Texas Children's Hospital and Houston Methodist Hospital, Houston, TX, USA; Dan L Duncan Comprehensive Cancer Center, Houston, TX, USA; Department of Pediatrics, Texas Children's Hospital, Houston, TX, USA., Krance R; Center for Cell and Gene Therapy, Baylor College of Medicine, Texas Children's Hospital and Houston Methodist Hospital, Houston, TX, USA; Dan L Duncan Comprehensive Cancer Center, Houston, TX, USA; Department of Pediatrics, Texas Children's Hospital, Houston, TX, USA., Ramos CA; Center for Cell and Gene Therapy, Baylor College of Medicine, Texas Children's Hospital and Houston Methodist Hospital, Houston, TX, USA; Dan L Duncan Comprehensive Cancer Center, Houston, TX, USA; Department of Pediatrics, Texas Children's Hospital, Houston, TX, USA., Rouce RH; Center for Cell and Gene Therapy, Baylor College of Medicine, Texas Children's Hospital and Houston Methodist Hospital, Houston, TX, USA; Dan L Duncan Comprehensive Cancer Center, Houston, TX, USA; Department of Pediatrics, Texas Children's Hospital, Houston, TX, USA., Lulla P; Center for Cell and Gene Therapy, Baylor College of Medicine, Texas Children's Hospital and Houston Methodist Hospital, Houston, TX, USA; Dan L Duncan Comprehensive Cancer Center, Houston, TX, USA., Heslop HE; Center for Cell and Gene Therapy, Baylor College of Medicine, Texas Children's Hospital and Houston Methodist Hospital, Houston, TX, USA; Dan L Duncan Comprehensive Cancer Center, Houston, TX, USA., Omer B; Center for Cell and Gene Therapy, Baylor College of Medicine, Texas Children's Hospital and Houston Methodist Hospital, Houston, TX, USA; Dan L Duncan Comprehensive Cancer Center, Houston, TX, USA; Department of Pediatrics, Texas Children's Hospital, Houston, TX, USA., Shekar M; Center for Cell and Gene Therapy, Baylor College of Medicine, Texas Children's Hospital and Houston Methodist Hospital, Houston, TX, USA; Department of Pediatrics, Texas Children's Hospital, Houston, TX, USA. Electronic address: Meghan.shekar@bcm.edu.
Publikováno v: Cytotherapy [Cytotherapy] 2024 Sep; Vol. 26 (9), pp. 1026-1032. Date of Electronic Publication: 2024 May 08.
Zobrazit plný text záznamu
8
Akademický článek
Selective refueling of CAR T cells using ADA1 and CD26 boosts antitumor immunity.
Autor: Hu Y; Department of Translational Medical Sciences, School of Medicine, Texas A&M University, Houston, TX, USA; Center for Infectious and Inflammatory Diseases, Institute of Biosciences and Technology, Texas A&M University, Houston, TX, USA., Sarkar A; Department of Translational Medical Sciences, School of Medicine, Texas A&M University, Houston, TX, USA; Center for Infectious and Inflammatory Diseases, Institute of Biosciences and Technology, Texas A&M University, Houston, TX, USA., Song K; Department of Translational Medical Sciences, School of Medicine, Texas A&M University, Houston, TX, USA; Center for Infectious and Inflammatory Diseases, Institute of Biosciences and Technology, Texas A&M University, Houston, TX, USA; Department of Biology, University of Houston, Houston, TX, USA., Michael S; Department of Translational Medical Sciences, School of Medicine, Texas A&M University, Houston, TX, USA; Center for Infectious and Inflammatory Diseases, Institute of Biosciences and Technology, Texas A&M University, Houston, TX, USA; Department of Synthesis Biology, University of Houston, Houston, TX, USA., Hook M; Department of Translational Medical Sciences, School of Medicine, Texas A&M University, Houston, TX, USA; Center for Infectious and Inflammatory Diseases, Institute of Biosciences and Technology, Texas A&M University, Houston, TX, USA., Wang R; Center for Childhood Cancer Research, Hematology/Oncology & BMT, Abigail Wexner Research Institute at Nationwide Children's Hospital, Department of Pediatrics at The Ohio State University, Columbus, OH, USA., Heczey A; Texas Children's Hospital, Houston, TX, USA; Department of Pediatric, Baylor College of Medicine, Houston, TX, USA., Song X; Department of Translational Medical Sciences, School of Medicine, Texas A&M University, Houston, TX, USA; Center for Infectious and Inflammatory Diseases, Institute of Biosciences and Technology, Texas A&M University, Houston, TX, USA. Electronic address: xsong@tamu.edu.
Publikováno v: Cell reports. Medicine [Cell Rep Med] 2024 May 21; Vol. 5 (5), pp. 101530. Date of Electronic Publication: 2024 Apr 29.
Zobrazit plný text záznamu
9
Interleukin-15-armored GPC3-CAR T cells for patients with solid cancers.
Autor: Steffin D; Texas Children's Cancer Center, Department of Pediatrics, Baylor College of Medicine, Houston, Texas.; Center for Advanced Innate Cell Therapy, Baylor College of Medicine, Houston, Texas.; Dan L Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, Texas.; Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, Texas., Ghatwai N; Texas Children's Cancer Center, Department of Pediatrics, Baylor College of Medicine, Houston, Texas.; Center for Advanced Innate Cell Therapy, Baylor College of Medicine, Houston, Texas., Montalbano A; Texas Children's Cancer Center, Department of Pediatrics, Baylor College of Medicine, Houston, Texas.; Center for Advanced Innate Cell Therapy, Baylor College of Medicine, Houston, Texas., Rathi P; Texas Children's Cancer Center, Department of Pediatrics, Baylor College of Medicine, Houston, Texas.; Center for Advanced Innate Cell Therapy, Baylor College of Medicine, Houston, Texas., Courtney AN; Texas Children's Cancer Center, Department of Pediatrics, Baylor College of Medicine, Houston, Texas.; Center for Advanced Innate Cell Therapy, Baylor College of Medicine, Houston, Texas.; Dan L Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, Texas., Arnett AB; Center for Advanced Innate Cell Therapy, Baylor College of Medicine, Houston, Texas.; Department of Immunology and Microbiology, Baylor College of Medicine, Texas., Fleurence J; Texas Children's Cancer Center, Department of Pediatrics, Baylor College of Medicine, Houston, Texas.; Dan L Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, Texas., Sweidan R; Department of Immunology and Microbiology, Baylor College of Medicine, Texas., Wang T; Dan L Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, Texas., Zhang H; Department of Immunology and Microbiology, Baylor College of Medicine, Texas., Masand P; Department of Radiology, Baylor College of Medicine, Houston, Texas., Maris JM; Department of Pediatrics, Children's Hospital of Philadelphia and Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania., Martinez D; Pathology and Laboratory Medicine, Children's Hospital of Philadelphia and Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania., Pogoriler J; Pathology and Laboratory Medicine, Children's Hospital of Philadelphia and Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania., Varadarajan N; William A. Brookshire Department of Chemical and Biomolecular Engineering, University of Houston, Houston, Texas., Thakkar SG; Department of Immunology and Microbiology, Baylor College of Medicine, Texas., Lyon D; Department of Immunology and Microbiology, Baylor College of Medicine, Texas., Lapteva N; Department of Immunology and Microbiology, Baylor College of Medicine, Texas.; Department of Pathology and Immunology, Baylor College of Medicine, Houston, Texas.; Department of Pathology, Baylor College of Medicine, Houston, Texas., Mei Z; Department of Immunology and Microbiology, Baylor College of Medicine, Texas., Patel K; Department of Pathology, Baylor College of Medicine, Houston, Texas., Lopez-Terrada D; Department of Pathology, Baylor College of Medicine, Houston, Texas., Ramos C; Dan L Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, Texas.; Department of Immunology and Microbiology, Baylor College of Medicine, Texas., Lulla P; Dan L Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, Texas.; Department of Immunology and Microbiology, Baylor College of Medicine, Texas., Armaghany T; Dan L Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, Texas., Grilley BJ; Texas Children's Cancer Center, Department of Pediatrics, Baylor College of Medicine, Houston, Texas.; Center for Advanced Innate Cell Therapy, Baylor College of Medicine, Houston, Texas.; Dan L Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, Texas.; Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, Texas., Dotti G; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, North Carolina., Metelitsa LS; Texas Children's Cancer Center, Department of Pediatrics, Baylor College of Medicine, Houston, Texas.; Center for Advanced Innate Cell Therapy, Baylor College of Medicine, Houston, Texas.; Dan L Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, Texas.; Department of Immunology and Microbiology, Baylor College of Medicine, Texas., Heslop HE; Dan L Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, Texas.; Department of Immunology and Microbiology, Baylor College of Medicine, Texas., Brenner MK; Dan L Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, Texas.; Department of Immunology and Microbiology, Baylor College of Medicine, Texas., Sumazin P; Texas Children's Cancer Center, Department of Pediatrics, Baylor College of Medicine, Houston, Texas.; Dan L Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, Texas., Heczey A; Texas Children's Cancer Center, Department of Pediatrics, Baylor College of Medicine, Houston, Texas.; Center for Advanced Innate Cell Therapy, Baylor College of Medicine, Houston, Texas.; Dan L Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, Texas.; Texas Children's Hospital Liver Tumor Program, Houston, Texas.
Publikováno v: Research square [Res Sq] 2024 Apr 03. Date of Electronic Publication: 2024 Apr 03.
Zobrazit plný text záznamu
10
Author Correction: Anti-GD2 CAR-NKT cells in relapsed or refractory neuroblastoma: updated phase 1 trial interim results.
Autor: Heczey A; Department of Pediatrics, Center for Advanced Innate Cell Therapy, Baylor College of Medicine, Houston, TX, USA. heczey@bcm.edu.; Department of Medicine, Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, TX, USA. heczey@bcm.edu., Xu X; Department of Pediatrics, Center for Advanced Innate Cell Therapy, Baylor College of Medicine, Houston, TX, USA., Courtney AN; Department of Pediatrics, Center for Advanced Innate Cell Therapy, Baylor College of Medicine, Houston, TX, USA., Tian G; Department of Pediatrics, Center for Advanced Innate Cell Therapy, Baylor College of Medicine, Houston, TX, USA., Barragan GA; Department of Pediatrics, Center for Advanced Innate Cell Therapy, Baylor College of Medicine, Houston, TX, USA., Guo L; Department of Pediatrics, Center for Advanced Innate Cell Therapy, Baylor College of Medicine, Houston, TX, USA., Amador CM; Department of Pediatrics, Center for Advanced Innate Cell Therapy, Baylor College of Medicine, Houston, TX, USA., Ghatwai N; Department of Pediatrics, Center for Advanced Innate Cell Therapy, Baylor College of Medicine, Houston, TX, USA., Rathi P; Department of Pediatrics, Center for Advanced Innate Cell Therapy, Baylor College of Medicine, Houston, TX, USA., Wood MS; Department of Pediatrics, Center for Advanced Innate Cell Therapy, Baylor College of Medicine, Houston, TX, USA., Li Y; Department of Pediatrics, Center for Advanced Innate Cell Therapy, Baylor College of Medicine, Houston, TX, USA., Zhang C; Department of Pediatrics, Center for Advanced Innate Cell Therapy, Baylor College of Medicine, Houston, TX, USA., Demberg T; Department of Pediatrics, Center for Advanced Innate Cell Therapy, Baylor College of Medicine, Houston, TX, USA., Di Pierro EJ; Department of Pediatrics, Center for Advanced Innate Cell Therapy, Baylor College of Medicine, Houston, TX, USA., Sher AC; Department of Radiology, Texas Children's Hospital, Baylor College of Medicine, Houston, TX, USA., Zhang H; Department of Medicine, Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, TX, USA., Mehta B; Department of Medicine, Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, TX, USA., Thakkar SG; Department of Medicine, Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, TX, USA., Grilley B; Department of Medicine, Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, TX, USA., Wang T; Biostatistics and Data Management Resource, Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX, USA., Weiss BD; Department of Pediatrics, Cincinnati Children's Hospital, Cincinnati, OH, USA., Montalbano A; Immunai, Inc., New York, NY, USA., Subramaniam M; Immunai, Inc., New York, NY, USA., Xu C; Immunai, Inc., New York, NY, USA., Sachar C; Immunai, Inc., New York, NY, USA., Wells DK; Immunai, Inc., New York, NY, USA., Dotti G; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Metelitsa LS; Department of Pediatrics, Center for Advanced Innate Cell Therapy, Baylor College of Medicine, Houston, TX, USA. lsmeteli@txch.org.; Department of Medicine, Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, TX, USA. lsmeteli@txch.org.
Publikováno v: Nature medicine [Nat Med] 2024 Apr; Vol. 30 (4), pp. 1210.
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje